Park Ha Biological Technology is trading 5.35% down at $3.36 after an August 12 securities class-action reminder reiterated the September 28 lead-plaintiff deadline.
- The lawsuit alleges misleading disclosures, social-media misinformation, impersonated financial professionals, artificial trading activity, and an unusually low public float; these allegations remain unproven.
- The broader market is higher, so the litigation reminder appears to be the primary company-specific pressure.
- Shares remain highly volatile after an 875.46% jump on August 6 and a 9.87% gain on August 10.